Thursday
SESSION 16: INTERVENTIONAL RADIOLOGISTS’ ROLE IN THE MANAGEMENT OF METASTATIC DISEASE
Moderators:Andreas Kaubisch, MD / Jacob Cynamon, MD  
SESSION 16 SCHEDULE
1:30 PM - 1:40 PM Colorectal Mets Management: An Overview
  Presenter(s):Andreas Kaubisch, MD  
1:40 PM - 1:50 PM When Is Surgical Resection Best?
  Presenter(s):Milan Kinkhabwala, MD  
1:50 PM - 2:00 PM Portal Vein Embolization: Indications, Tips And Tricks
  Presenter(s):David C. Madoff, MD  
2:00 PM - 2:10 PM Why Y90 Should Be The Treatment Of Choice For Most Metastatic Liver Lesions
  Presenter(s):Matthew S. Johnson, MD  
2:10 PM - 2:20 PM Tailored Radioembolization: Diffuse Liver vs. Lobectomy
  Presenter(s):Daniel Y. Sze, MD, PhD  
2:20 PM - 2:30 PM Technical Considerations For Optimizing Y90 Outcomes
  Presenter(s):Riad Salem, MD, MBA  
2:30 PM - 2:40 PM Role Of DEBIRI/Ablation: Current Role Of Combination Therapy In CRC Liver Mets
  Presenter(s):Riccardo Lencioni, MD  
2:40 PM - 2:50 PM Metastatic Disease: When Should You Use TACE, Y90 Or ChemoSaturation?
  Presenter(s):Daniel B. Brown, MD  
2:50 PM - 3:00 PM US Experience With ChemoSaturation
  Presenter(s):Krishna kandarpa, MD, PhD  
3:00 PM - 3:10 PM Initial European Institute of Oncology (EIO) Experience With Hepatic ChemoSaturation
  Presenter(s):Pier Francesco Ferrucci, MD, PhD  
3:10 PM - 3:20 PM Panel Discussion
END OF SESSION 16
previous next